Literature DB >> 20656834

MR imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: preclinical feasibility studies in a rodent model.

Yue Zhang1, Yang Guo, Ann B Ragin, Robert J Lewandowski, Guang-Yu Yang, Grace M Nijm, Alan V Sahakian, Reed A Omary, Andrew C Larson.   

Abstract

PURPOSE: To test the hypothesis that magnetic resonance (MR) imaging measurements can be used to immediately detect treated tissue regions after irreversible electroporation (IRE) ablation procedures in rodent liver tissues.
MATERIALS AND METHODS: All experiments received institutional animal care and use committee approval. In four rats for preliminary studies and 18 rats for formal assessment, MR imaging-compatible electrodes were inserted into the liver and MR imaging-monitored IRE procedures were performed at one of three electrode voltages (1000, 1500, or 2500 V), with T1- and T2-weighted images acquired before and immediately after application of the IRE pulses. MR imaging measurements were compared with both finite element modeling (FEM)-anticipated ablation zones and histologically confirmed ablation zones at necropsy. Intraclass and Spearman correlation coefficients were calculated for statistical comparisons.
RESULTS: MR imaging measurements permitted immediate depiction of IRE ablation zones that were hypointense on T1-weighted images and hyperintense on T2-weighted images. MR imaging-based measurements demonstrated excellent consistency with FEM-anticipated ablation zones (r > 0.90 and P < .001 for both T1- and T2-weighted images). MR imaging measurements were also highly correlated with histologically confirmed ablation zone measurements (rho > 0.90 and P < .001 for both T1- and T2-weighted images).
CONCLUSION: MR imaging permits immediate depiction of ablated tissue zones for monitoring of IRE ablation procedures. These measurements could potentially be used during treatment to elicit repeat application of IRE pulses or adjustments to electrode positions to ensure complete treatment of targeted lesions.

Entities:  

Mesh:

Year:  2010        PMID: 20656834      PMCID: PMC2909436          DOI: 10.1148/radiol.10091955

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  32 in total

1.  Clinical applications of electrochemotherapy.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-01-04       Impact factor: 15.470

Review 2.  Magnetic resonance temperature imaging for guidance of thermotherapy.

Authors:  B Quesson; J A de Zwart; C T Moonen
Journal:  J Magn Reson Imaging       Date:  2000-10       Impact factor: 4.813

3.  Temperature quantitation and mapping of frozen tissue.

Authors:  K Butts; J Sinclair; B L Daniel; J Wansapura; J M Pauly
Journal:  J Magn Reson Imaging       Date:  2001-01       Impact factor: 4.813

4.  Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation.

Authors:  Edward W Lee; Christopher T Loh; Stephen T Kee
Journal:  Technol Cancer Res Treat       Date:  2007-08

5.  Irreversible electroporation: implications for prostate ablation.

Authors:  Gary Onik; Paul Mikus; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2007-08

6.  Structural and functional recovery of electropermeabilized skeletal muscle in-vivo after treatment with surfactant poloxamer 188.

Authors:  John M Collins; Florin Despa; Raphael C Lee
Journal:  Biochim Biophys Acta       Date:  2007-01-25

7.  In vivo NMR imaging evaluation of efficiency and toxicity of gene electrotransfer in rat muscle.

Authors:  A Leroy-Willig; M F Bureau; D Scherman; P G Carlier
Journal:  Gene Ther       Date:  2005-10       Impact factor: 5.250

8.  Assessment of protamine-induced thrombosis of tumor vessels for cancer therapy using dynamic contrast-enhanced MRI.

Authors:  Min-Ying Su; Michael K Samoszuk; Jun Wang; Orhan Nalcioglu
Journal:  NMR Biomed       Date:  2002-04       Impact factor: 4.044

9.  Dynamic contrast-enhanced magnetic resonance imaging as a predictor of clinical outcome in canine spontaneous soft tissue sarcomas treated with thermoradiotherapy.

Authors:  Benjamin L Viglianti; Michael Lora-Michiels; Jeanie M Poulson; Lan Lan; Daohai Yu; Dahio Yu; Linda Sanders; Oana Craciunescu; Zeljko Vujaskovic; Donald E Thrall; James Macfall; Cecil H Charles; Terence Wong; Mark W Dewhirst
Journal:  Clin Cancer Res       Date:  2009-07-21       Impact factor: 12.531

10.  High-voltage electric injury: assessment of muscle viability with MR imaging and Tc-99m pyrophosphate scintigraphy.

Authors:  J L Fleckenstein; D P Chason; F J Bonte; R W Parkey; J L Hunt; G F Purdue; D K Burns
Journal:  Radiology       Date:  1995-04       Impact factor: 11.105

View more
  28 in total

1.  Electroporation-mediated transcatheter arterial chemoembolization in the rabbit VX2 liver tumor model.

Authors:  Yang Guo; Yue Zhang; Ning Jin; Rachel Klein; Jodi Nicolai; Robert J Lewandowski; Robert K Ryu; Reed A Omary; Andrew C Larson
Journal:  Invest Radiol       Date:  2012-02       Impact factor: 6.016

2.  Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablation.

Authors:  Zhuoli Zhang; Weiguo Li; Daniel Procissi; Patrick Tyler; Reed A Omary; Andrew C Larson
Journal:  Nanomedicine (Lond)       Date:  2013-09-11       Impact factor: 5.307

3.  Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors.

Authors:  Samdeep K Mouli; Patrick Tyler; Joseph L McDevitt; Aaron C Eifler; Yang Guo; Jodi Nicolai; Robert J Lewandowski; Weiguo Li; Daniel Procissi; Robert K Ryu; Y Andrew Wang; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  ACS Nano       Date:  2013-08-20       Impact factor: 15.881

4.  Diffusion MRI biomarkers predict the outcome of irreversible electroporation in a pancreatic tumor mouse model.

Authors:  Matteo Figini; Xifu Wang; Tianchu Lyu; Zhanliang Su; Bin Wang; Chong Sun; Junjie Shangguan; Liang Pan; Kang Zhou; Quanhong Ma; Vahid Yaghmai; Daniele Procissi; Andrew C Larson; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

5.  Preclinical and clinical evaluation of the liver tumor irreversible electroporation by magnetic resonance imaging.

Authors:  Matteo Figini; Xifu Wang; Tianchu Lyu; Zhanliang Su; Daniele Procissi; Vahid Yaghmai; Andrew C Larson; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

6.  18F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model.

Authors:  Xifu Wang; Zhanliang Su; Tianchu Lyu; Matteo Figini; Daniel Procissi; Junjie Shangguan; Chong Sun; Bin Wang; Na Shang; Shanzhi Gu; Quanhong Ma; Andrew C Gordon; Kai Lin; Jian Wang; Robert J Lewandowski; Riad Salem; Vahid Yaghmai; Andrew C Larson; Zhuoli Zhang
Journal:  Radiology       Date:  2017-12-12       Impact factor: 11.105

7.  Irreversible electroporation in the liver: contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones.

Authors:  Yang Guo; Yue Zhang; Grace M Nijm; Alan V Sahakian; Guang-Yu Yang; Reed A Omary; Andrew C Larson
Journal:  Radiology       Date:  2010-12-03       Impact factor: 11.105

8.  DWI and DCE-MRI approaches for differentiating reversibly electroporated penumbra from irreversibly electroporated ablation zones in a rabbit liver model.

Authors:  Anna J Shangguan; Chong Sun; Bin Wang; Liang Pan; Quanhong Ma; Su Hu; Jia Yang; Aydin Eresen; Yuri Velichko; Vahid Yaghmai; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

9.  Diffusion-weighted MRI for verification of electroporation-based treatments.

Authors:  Faisal Mahmood; Rasmus H Hansen; Birgit Agerholm-Larsen; Kurt S Jensen; Helle K Iversen; Julie Gehl
Journal:  J Membr Biol       Date:  2011-03-06       Impact factor: 1.843

10.  Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model.

Authors:  Yue Zhang; Sarah B White; Jodi R Nicolai; Zhuoli Zhang; Derek L West; Dong-Hyun Kim; A Lee Goodwin; Frank H Miller; Reed A Omary; Andrew C Larson
Journal:  Radiology       Date:  2014-02-18       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.